VI

Healthcare · Healthcare Research, Analytics & Technology

Vimta Labs Ltd (VIMTALABS)

₹467.65

Mkt cap
₹2,230 Cr
P/E ratio
27.40
P/B
4.25
Div yield
0.40%
ROE
18.90%
ROCE
25.20%
EPS (TTM)
₹17.07
Book value
₹110
52W range
376–675
Sector
Healthcare

Price history

Previous close

Incorporated in 1990, Vimta Labs Ltd is a contract research and testing services provider [1]

NSE VIMTALABSBSE 524394
Health check
Constructive
ValuationFair
ProfitabilityStrong
GrowthModerate
TechnicalsNeutral
52-week range
−30.72% from high
₹468
₹376+24.36% from low₹675
Current
₹467.65
Prev close
₹471.95
Day
−0.91%
Price performance
1D
−1.05%
1W
−6.39%
1M
−4.59%
3M
−27.08%
6M
+3.71%
1Y
−26.88%
YTD
−23.36%

Financials

Revenue, profit & margin
P/E ratio
27.4×
VIMTALABS is 4% above the sector median of 26.4×
VIMTALABS27.4×
Sector median26.4×
 Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026Trend
Sales647373758590949810299109109112
YoY Sales growth-19%-5%-10%-9%+32%+23%+30%+30%+20%+10%+16%+12%+10%
Expenses48504749555761646864707274
Operating Profit17232626303333343434393738
OPM %26%31%36%35%35%37%35%35%34%35%36%34%34%
Other Income0-1-1-1-152230343
Interest1110010000000
Depreciation98888109101011131313
Profit before tax8131617202825252623292828
Tax %25%25%24%26%24%23%27%25%24%25%27%26%25%
Net Profit691212152218192018212121
EPS in Rs1.342.142.792.773.444.844.124.244.473.944.734.714.61
Raw PDF

Earnings

Results dates & reactions
No upcoming results date on calendar.

Fresh quarters land in the Financials table above, tagged NSE until screener catches up.

Avg earnings-day move −0.27% · closed higher next day 1 of last 1
 Q2FY27
Broadcast30 Oct '26
Earnings day−0.27%
+1 day+0.13%
+5 days+4.04%
+15 days—
+30 days—
FilingXBRL

Corporate actions

Last 6 months

No recent corporate actions

Dividends, splits, and bonuses in the last six months show up here.

Shareholding

as of Sep 2026
35.64%Promoter
Promoters35.64%0.02
FIIs5.07%0.66
DIIs0.48%0.11
Public58.79%0.76
Ownership trend

Peers

7 companies
Valuation vs quality
P/E × ROCE · bubble = market cap
NameCMPP/EMkt CapDiv YldNP QtrQtr Profit VarSales QtrQtr Sales VarROCE
Syngene Intl.₹444.3067.4617,9350.28%32−45.17%833−8.55%9.99%
Indegene₹666.2037.6416,0550.34%112+9.99%1,122+39.55%18.82%
Suven Life Scie.₹277.80—7,8500.00%−107−38.33%1+30.43%−79.54%
Vimta Labs₹498.9027.372,2300.40%21+3.46%112+9.95%25.23%
Fabtech Tech.₹139.7820.876210.43%15−67.06%92−24.19%13.88%
Novelix Pharma.₹70.0542.891990.00%2+194.34%45+23.02%10.87%
Bilcare₹84.435.461990.00%1+175.74%248+39.41%7.06%
Median: 9 Co.₹139.7826.386210.00%3+9.99%92+26.73%10.87%

Filings